THE (8;21) TRANSLOCATION IDENTIFIES A SUBGROUP OF ACUTE MYELOID LEUKEMIA (AML) WITH A RELATIVELY GOOD PROGNOSIS WHICH MAY REQUIRE A DIFFERENT TREATMENT. IT IS USUALLY ASSOCIATED WITH AML SUBTYPE M2. DETECTION OF T(8;21) HAS DIAGNOSTIC, PROGNOSTIC & THERAPEUTIC IMPLICATIONS FOR THE PATIENT.
Why book with us?
Free and On Schedule Sample Collection
24/7 Service
Affordable
Quick and Accurate Reports
5 ML (3 ML MIN.) WHOLE BLOOD OR 4 ML ( 2 ML MIN.) BONE MARROW FROM 2 GREEN TOP (SODIUM HEPARIN) TUBES. SHIP AT 18-22 C. DO NOT FREEZE.